Hoag Turns the Tables on Pancreatic Cancer
NEWPORT BEACH, Calif., July 16, 2018 --- Among cancer types, pancreatic cancer is one of the most ruthless killers. Growing quietly, with no discernible symptoms, pancreatic cancer is usually undetected until it has grown too advanced to treat effectively. Unlike most cancers, pancreatic cancer kills nearly as many people each year as those who develop the disease, with a majority of people dying within the first eight months of detection.
But it doesn’t have to be this way. Hoag Memorial Hospital Presbyterian is one of the first hospitals in the nation to create a program targeted at finding pancreatic cancer early, when it might still be treatable.
The Anita Erickson Pancreatic Cancer Early Detection Program offers people who have a family history the opportunity to receive testing and aggressive surveillance in hopes of finding cancer early enough for treatment.
“Typically, pancreatic cancer is identified at a late stage, where medical intervention is very limited,” said Valentina Dalili-Shoaie, M.D., medical geneticist and one of the physician leaders for the early detection program. “But if we can proactively monitor these patients at higher risk and detect cancer at an early stage, we can successfully surgically remove the tumors and increase survival rates.”
Hoag’s team includes a geneticist, genetic counselors, gastroenterologists, GI surgeons and a clinical nurse navigator who work together to detect early stage pancreatic cancer through labs, imaging and diagnostic testing, as well as genetic counseling and testing.